The Latest Cardiac and Vascular News
London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system, Evolut™ FX, significantly improved commissure alignment during TAVR procedures compared to […]
Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes DUBLIN, Nov. 22, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2023, […]
DUBLIN and CHICAGO, Nov. 7, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The data were presented today as Late-Breaking Clinical Science at the […]
CARLSBAD, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has achieved the […]
New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide DUBLIN, Oct. 26, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch […]
Medtronic “conduction system pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates DUBLIN, Oct. 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it […]
DUBLIN, Sept. 21, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes due 2025, […]
Getinge announces a supply partnership with Medtronic, which recently received CE mark for the Radiant™ covered stent, the first covered stent indicated for chimney endovascular aneurysm repair (ChEVAR). The Radiant covered stent is a private labeled Advanta V12 balloon expandable […]
Long-term analysis from landmark renal denervation trial presented as Late Breaking Clinical Science, published simultaneously in The Lancet Data add to growing body of evidence supporting the durability of the Symplicity blood pressure procedure DUBLIN and BOSTON, Sept. 18, 2022 /PRNewswire/ — Medtronic plc ( NYSE: MDT), […]
DUBLIN, Sept. 15, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. (“Medtronic Luxco”), has priced an offering (the “Offering”) of €500,000,000 principal amount of 2.625% senior notes due 2025, €1,000,000,000 principal amount […]
